Sign in

NCT04792684Recruiting

Collection of Samples USOPTIVAL Study

Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance ("USOPTIVAL")

Source: ClinicalTrials.gov · Last updated 10 Nov 2025

Brief summary (registry, in English)

A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1300 (estimated)
First submitted
8 Mar 2021
Start date
30 Dec 2020
Primary completion date
30 Dec 2025
Lead sponsor
Universal Diagnostics
NCT number
NCT04792684

What you commit to

  • Study type: Observational
  • Planned participants: 1300
  • From 30 Dec 2020 to the primary completion date, 30 Dec 2025
  • 16 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects having undergone previous partial surgical removal of one or more portions of their colon due to a reason other than colorectal cancer.
  • The patient has a known or documented previous or current medical history of infectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV, etc.), including patients that have been treated, are currently being treated, or have not been treated for that conditions.

Other illness

  • Subject has a current diagnosis of cancer.
    • Arms A \& B:
  • Subject has a personal history of aerodigestive or digestive tract cancers.
  • A significant disease which, in the Investigator's opinion, would exclude the subject from the study.
  • Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent.

Age

  • Has a known diagnosis or personal history of any of the following high-risk indications for colorectal cancer:
    • Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease.
    • Familial adenomatous polyposis ("FAP", including attenuated FAP).
    • Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "Lynch Syndrome").
    • Serrated polyposis syndrome
    • 2 first-degree relatives (e.g., parents, siblings, and offspring) who have been diagnosed with colon cancer.
    • One first-degree relative with CRC diagnosed before the age of 60.

Other

  • Arm A Only:
  • 1\. Subject with curative biopsy during colonoscopy.
  • Arm B Only:
  • Subjects with positive FIT Test results in the 6 months preceding enrollment.
  • Legal incapacity or limited mental capacity.
  • The patient is known to be pregnant when recruited or during her participation in the study.

Who the study is looking for

  • Arm A:
  • Must be 45-84 years of age.
  • Must have a suspected advanced adenoma or be newly diagnosed with CRC, still not resected, and scheduled for surgery.
  • Able to comprehend, sign, and date the written informed consent document.
    • Arm B:
  • Must be 45-84 years of age.
  • Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.
  • Able to comprehend, sign, and date the written informed consent document.

Age in the registry: 45 years to 84 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (16)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesCompleted
Precision Recearch Institute
Coordinator of this site? Confirm its status
Chula VistaUnited StatesCompleted
Center for Gastrointestinal Disorders
Coordinator of this site? Confirm its status
HollywoodUnited StatesCompleted
Vilo Research Group
Coordinator of this site? Confirm its status
HoustonUnited StatesCompleted
Lakeland Regional Cancer Center
Coordinator of this site? Confirm its status
LakelandUnited StatesRecruiting
Ochsner Clinic
Coordinator of this site? Confirm its status
New OrleansUnited StatesCompleted
Mid Hudson Medical Research
Coordinator of this site? Confirm its status
New WindsorUnited StatesRecruiting
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Fox Chase Cancer Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesCompleted
Gastroenterology Consultants of SW Virginia
Coordinator of this site? Confirm its status
RaonokeUnited StatesCompleted
Precision Research Institute
Coordinator of this site? Confirm its status
San DiegoUnited StatesCompleted
Medical Associates Research Group
Coordinator of this site? Confirm its status
San DiegoUnited StatesCompleted
Springfield Clinic
Coordinator of this site? Confirm its status
SpringfieldUnited StatesRecruiting
Clinical Trials Network
Coordinator of this site? Confirm its status
Union CityUnited StatesCompleted
Frontier Clinical Research
Coordinator of this site? Confirm its status
UniontownUnited StatesCompleted
Clinical Research of California
Coordinator of this site? Confirm its status
Walnut CreekUnited StatesCompleted

This page is information, not medical advice. Discuss any trial with your doctor.